Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Valvular Heart Disease
1997
Significance of coronary circulation in hypertensive heart disease for development and prevention of heart failure
1990
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
The Current Therapy for Mitral Regurgitation
2008
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Immunohistological diagnosis of myocarditis Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury
1998
Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension
1991
Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure
1988
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Burden of valvular heart diseases: a population-based study
2006 Standout
The spectrum of diseases of small coronery arteries and their physiologic consequences
1990
Myocarditis
2000 Standout
Hypertrophic Cardiomyopathy
2002 Standout
Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension
1990
Mitral valve repair in the treatment of mitral regurgitation
2009
Mitral valve surgery in patients with severe left ventricular dysfunction
2000
Effect of long-term treatment with $beta;-blocker on cardiac hypertrophy in SHR
1989
Homocysteine and Atherothrombosis
1998 Standout
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
2000 Standout
Human viral cardiomyopathy
2003
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy.
1989
Myocarditis
2006 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
1991 Standout
Myocardial oxygen consumption in chronic heart disease: Role of wall stress, hypertrophy and coronary reserve
1979
Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or β-Blockade in Patients With Essential Hypertension
2004
Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease
1981
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
1990 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans
2002 Standout
Valve Replacement for Regurgitant Lesions of the Aortic or Mitral Valve in Advanced Left Ventricular Dysfunction
1995
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation
1979
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Positron Tomography and Nuclear Magnetic Resonance Imaging
1982 StandoutScienceNobel
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.
1996
Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.
1993
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
1996 Standout
Meta-analysis of the association of enteroviruses with human heart disease
1997
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
2004
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Hypertension and Left-Ventricular Hypertrophy
1995
Works of Strauer Be being referenced
Methylprednisolone in chronic myocarditis.
1994
Quantitative determination of coronary reserve in diagnosis of coronary circulatory disorders
1977
[Dysplastic intramyocardial arteries with subaortic septum in patients with hypertrophic obstructive cardiomyopathy].
1992
Coronary flow reserve in arterial hypertension.
1989
[Transient myocardial ischemia in hypertensive patients].
1989
[The heart in hypertension. I. Left ventricular function at rest and during exercise (author's transl)].
1978
[Hypertension and the heart].
1988
Impaired Coronary Flow Reserve in NIDDM: A Possible Role for Diabetic Cardiopathy in Humans
1997
[Physiopathology and clinical aspects of pulmonary embolism].
1984
The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study.
1993
[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].
1994
The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
1985
Myocardial mechanics and oxygen consumption in experimental hyperthyroidism.
1975
[Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
1995
[Coronary hemodynamics and myocardial oxygen consumption in patients with left-ventricular hypertrophy].
1972